What is it about?

Synthetic cannabinoids which is a subgroup of cannabinoids are commonly used for recreational drug use throughout the whole world. Although both marijuana and synthetic cannabinoids stimulate the same receptors, cannabinoid receptor 1 (CB1) and cannabinoid receptor 2 (CB2), studies have shown that synthetic cannabinoids are much more potent than marijuana. The longer use of synthetic cannabinoids can cause severe physical and psychological symptoms that might even result in death, similar to many known illicit drugs. Main treatment options mostly involve symptom management and supportive care. The aim of this article is to discuss the clinical and pharmacological properties of the increasingly used synthetic cannabinoids.

Featured Image

Why is it important?

This article is to discuss the clinical and pharmacological properties of the increasingly used synthetic cannabinoids, in the last years.

Read the Original

This page is a summary of: Sentetik Kannabinoidler, Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry, September 2017, Current Approaches in Psychiatry,
DOI: 10.18863/pgy.270396.
You can read the full text:

Read

Contributors

The following have contributed to this page